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ABSTRACT
Influenza A virus segment 2 mRNA expresses three
polypeptides: PB1, PB1-F2 and PB1-N40, from AUGs
1, 4 and 5 respectively. Two short open reading
frames (sORFs) initiated by AUGs 2 and 3 are also
present. To understand translational regulation in
this system, we systematically mutated AUGs 1–4
and monitored polypeptide synthesis from
plasmids and recombinant viruses. This identified
sORF2 as a key regulatory element with opposing
effects on PB1-F2 and PB1-N40 expression. We
propose a model in which AUGs 1–4 are accessed
by leaky ribosomal scanning, with sORF2 repressing
synthesis of downstream PB1-F2. However, sORF2
also up-regulates PB1-N40 expression, most likely
by a reinitiation mechanism that permits skipping of
AUG4. Surprisingly, we also found that in contrast to
plasmid-driven expression, viruses with improved
AUG1 initiation contexts produced less PB1 in
infected cells and replicated poorly, producing
virions with elevated particle:PFU ratios. Analysis
of the genome content of virus particles showed
reduced packaging of the mutant segment
2 vRNAs. Overall, we conclude that segment
2 mRNA translation is regulated by a combination
of leaky ribosomal scanning and reinitiation, and
that the sequences surrounding the PB1 AUG
codon are multifunctional, containing overlapping
signals for translation initiation and for segment-
specific packaging.
INTRODUCTION
Inﬂuenza A virus (IAV) is a major pathogen, capable of
infecting a number of species including humans, birds,
swine and horses. Its genome is contained on eight
segments of negative sense viral RNA (vRNA), individu-
ally complexed with the trimeric viral polymerase
(PB2, PB1 and PA) and nucleoprotein (NP) to form
ribonucleoprotein (RNP) particles (1). On infection, the
RNPs migrate to the nucleus where the polymerase initial-
ly transcribes the vRNA templates to produce mRNA,
and later replicates the genome using positive sense
cRNA intermediates (2). Subsequently, new vRNAs are
exported from the nucleus (as RNPs) and packaged into
progeny virus particles at the plasma membrane. As each
segment encodes at least one essential gene product, a
viable virus particle must contain one copy of each
segment, which is facilitated via speciﬁc cis-acting
packaging signals present in the terminal non-coding
and coding regions of each vRNA (3). IAV strains also
show considerable variation in pathogenicity, and the mo-
lecular mechanisms underlying this have not been fully
elucidated. Segment 2 encodes PB1, the core component
of the viral polymerase, which has been linked to
inter-strain differences in pathogenicity and host range
(4,5). However, the single mRNA species transcribed
from the segment also encodes two further proteins that
are non-essential for virus replication: PB1-F2 and
PB1-N40 (6,7).
PB1-F2 is encoded by the+1 open reading frame (ORF)
relative to PB1 and is initiated from AUG4 (Figure 1A).
Depending on virus strain, the PB1-F2 ORF is up to
90 codons long, but in many viruses (including the
recent pandemic H1N1 virus, where the gene is effectively
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absent), is truncated to variable extents by one or more
stop codons (8,9). PB1-F2 polypeptides of 79 amino acids
or longer can localize to mitochondria and the protein has
been associated with pro-apoptotic and pro-inﬂammatory
effects (6,9–12). A proportion of the protein also localizes
to the nucleus where it interacts with PB1 and may
inﬂuence polymerase activity (13,14). In some strains of
virus, manipulating the expression or sequence of PB1-F2
altered replication and/or pathogenicity, leading to its
identiﬁcation as a virulence factor (6,10,14–17).
However, in many cases, the presence or absence of an
intact PB1-F2 ORF had little or no impact on virus rep-
lication in vitro or in vivo (7,8,17,18). Overall the contri-
bution the protein makes to IAV pathogenesis is
imperfectly understood.
Recently, we showed that AUG5 of segment 2 is also
used to initiate translation of a protein product called
PB1-N40, made at 5% of the abundance of PB1 (7).
AUG5 is in frame with AUG1, and so N40 is a truncated
form of PB1, lacking the ﬁrst 39 amino acids of the longer
polypeptide (Figure 1A). The ‘missing’ region is important
for the interaction of PB1 with PA (19), and therefore N40
should not be able to form the stable complex with PA
necessary for efﬁcient nuclear import and polymerase
function (20,21). Indeed, N40 predominantly localized
to the cytoplasm, and was not transcriptionally active
(7). A function for PB1-N40 has not yet been identiﬁed,
although PB1-N40 null viruses retaining an intact PB1-F2
ORF displayed delayed single cycle growth kinetics (7).
It has been suggested that leaky ribosomal scanning is
responsible for PB1-F2 and PB1 N40 expression (6,7,17).
In the scanning model of translation initiation, ribosomes
bind to the 50 end of mRNA and move along until they
recognize a start codon (22). The sequence context of
the AUG affects the probability that it will be recognized
as a bona ﬁde initiation codon; the Kozak consensus
GCC(A/G)CCAUGG, is thought to be optimal, with a
purine at 3 and G at +4 exerting the strongest effects
(23,24). In support of the ribosomal scanning hypothesis,
AUG1 is set in a medium strength Kozak consensus,
lacking a purine at 3 (Figure 1A and B), while
mutation of AUG4 has been shown to lead to up-
regulation of N40 translation from AUG5 (7). However,
the presence of two short ORFs (sORFs) initiated by
AUGs 2 and 3 upstream of the PB1-F2 and N40 AUGs
(Figure 1A and B) is suggestive of additional regulatory
Figure 1. Arrangement and sequence of ORFs in the 50-end of segment 2 mRNA and mutants used in this study. (A) Schematic diagram of ORFs at
the 50-end of segment 2 mRNA with AUG codons numbered according to their position and shaded according to the strength of their Kozak
consensus sequence (green, strong consensus, with A/G at 3 and G at+4; yellow, medium consensus with either A/G at 3 or G at+4; red is a
weak consensus U at –3 and +4). Adapted from (7). (B) Nucleotide sequence and site of mutations used in this study. The 50-end of segment
2 mRNA is shown in positive sense and as cDNA, since all mutations were introduced into a plasmid clone of the segment. (C) Summary of the
predicted effect of the mutations used in this study on AUG strength and ORF structure (non synonymous changes in PB1 are indicated after red
asterisks).
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complexities. Furthermore, a previous study that
investigated the effect of improving the Kozak consensus
of AUG1 found little effect on PB1 levels in virus infected
cells, and the authors suggested that start codon selection
was not the primary control element for segment 2 trans-
lation (25). Thus unresolved questions remain over the
control of segment 2 gene expression.
Here, we report a systematic investigation of the role of
the ﬁrst four AUG codons in segment 2 in directing viral
protein synthesis. Our ﬁndings indicate a modiﬁed leaky
scanning model in which translation initiation at internal
start codons is inﬂuenced by upstream AUGs, but where
sORF2 is a critical regulatory element that depresses
PB1-F2 synthesis but promotes N40 translation through
a reinitiation mechanism. Unexpectedly, we also found
that the translational regulatory sequences surrounding
AUGs 1 and 2 overlapped with sequences required for
packaging of the segment into virus particles, providing
an interesting insight into the evolutionary constraints
acting on this section of the viral genome.
MATERIALS AND METHODS
Cells, plasmids and antisera
Human embryonic kidney 293T cells and Madin-Darby
canine kidney (MDCK) cells were cultured by standard
methods. For transfections, 293T cells were transfected
in Optimem (Invitrogen) according to manufacturer’s in-
structions using Lipofectamine 2000 (Invitrogen).
Plasmids pcDNA-PB2, -PA and -NP, containing cDNA
copies of the inﬂuenza A/PR/8/34 (PR8) genes as well as
plasmid pPolI-Flu-ffLuc containing an inﬂuenza
virus-based luciferase minireplicon vRNA under the
control of the human RNA polymerase I (Pol I)
promoter have been previously described (7,26). Dual
promoter reverse genetics plasmids for PR8 segments 1
and 3–8 and a pPol-I segment 7 clone were donated by
Professor Ron Fouchier (27). A similar construct for
segment 2 cloned from the NIBSC strain of PR8 is
described in (7). To assess PB1-F2 expression in vitro, a
CAT fragment was ligated into SmaI/XbaI digested
pcDNA-PB1 in frames 1, 2 or 3. To analyse viral gene
expression from transfected plasmids, nucleotides 1–380
of EF467819 were subcloned into pEGFPN1 (Clontech)
as a AgeI/KpnI fragment. Site directed mutagenesis was
then employed to position the green ﬂuorescent protein
(GFP) ORF into frame with either the PB1 or PB1-F2
reading frames while concurrently removing the GFP
AUG codon. Additional segment 2 mutations as
detailed in the results section were made using site
directed mutagenesis with the wild-type segment
plasmids as templates. For brevity, the sequences of the
mutational oligonucleotides are not given but are avail-
able on request. All plasmids were sequence veriﬁed.
Rabbit polyclonal anti-PB1 serum V19 raised against
amino acids 50–370 of PR8 PB1 has been previously
described (28), as has rabbit polyclonal antiserum A2915
against PR8 NP (29). Rabbit antisera to the C-terminus of
the PB1-F2 protein and to the full length PB1-F2 protein
were kindly provided by Jonathan Yewdell. Rat
monoclonal anti-tubulin YL1/2 was purchased from
Serotec, anti-GFP mouse monoclonal JL8 from
Clontech and IR800 or IR680 dye conjugated anti-rabbit
IgG and anti-mouse IgG sera were purchased from LiCor.
Reverse genetics and virus titrations
Recombinant PR8 viruses were produced by transfection
of plasmids into 293T cells in suspension as previously
described (7,30). Rescued viruses were passaged once in
MDCK cells at an input MOI of  0.001, and where
indicated, once in 11-day-old embryonated eggs using an
inoculum of 1000PFU. Virus titres were determined by
plaque assay on MDCK cells (30), and the presence of
the desired mutations in segment 2 were conﬁrmed by
sequencing. Multiple independent rescues were performed
(minimum twice, mostly 3–6 times) to ensure that a given
phenotype did not result from adventitious mutations else-
where in the virus genome. Virus infections of MDCK
cells were performed at an MOI of 3–5 in serum free
media for 30min at 37C, after which cells were overlaid
with serum-containing media. Haemagglutination (HA)
assays were performed as previously described (30).
Protein analyses
Coupled in vitro transcription–translation reactions were
carried out in rabbit reticulocyte lysate using the Promega
TNT system according to the manufacturer’s instructions.
SDS–PAGE followed by coomassie blue staining
(to ensure equal loading of samples) and autoradiography
was performed according to standard procedures. Blots
were imaged using infrared ﬂuorescence of appropriately
tagged secondary antibodies and quantiﬁed using a
LiCOR Odyssey scanner and software. Transcriptional
activity of reconstituted RNPs was assessed using
pPolI-Flu-ffLuc or pPol-I segment 7 as reporter
plasmids. An amount of 50 ng of 3PNP and 20 ng of the
reporter were transfected into adherent 293T cells and 48 h
later, either luciferase levels from passively lysed cells
were measured using a Promega GloMax luminometer
or total RNA was extracted and segment 7 mRNA
levels determined by reverse-transcriptase primer
extension.
RNA analyses
The vRNA content of virus particles was determined
by silver staining as previously described (30,31).
Quantitative RT–PCR (qRT–PCR) for segments 2, 3, 5
and 7 was also performed on RNA extracted from equal
PFU using the QIASymphony system (Qiagen) as previ-
ously described (30,31). Reverse transcriptase primer ex-
tension analysis of RNA from infected or transfected
cells was performed as described (32), with the exception
that SuperscriptIII (Invitrogen) was used and reverse tran-
scription was performed at 50C. Reaction conditions,
primer and probe sequences are available upon request.
Quantiﬁcation was performed by densitometry of scanned
X-ray ﬁlms using Image J (Research Services Branch,
NIH). Values were corrected with respect to a loading
control (cellular 5S ribosomal RNA) and normalized to
those of WT virus.
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RESULTS
Segment 2 mRNA is known to encode three polypeptides:
PB1 and PB1-N40 in frame 1, and PB1-F2 in frame 2
(6,7), translated from AUGs 1, 5 and 4 respectively
(Figure 1A). The sub-optimal Kozak consensus ﬂanking
AUG1 prompted the hypothesis that the PB1-F2 ORF is
accessed by leaky ribosomal scanning (6) and consistent
with this, we previously showed that there was increased
translation from AUG5 in the absence of AUG4 (7).
However, there are two intervening start codons in
frame 2 between AUG1 and the PB1-F2 ORF that
initiate short sORFs with minimal protein coding
capacity; eight and two codons respectively (Figure 1A
and B). Nevertheless, both these AUGs are highly
conserved, being present in >99% of the available
segment 2 sequences, similar to the conservation shown
by AUGs 4 and 5 for PB1-F2 and N40 respectively
(Table 1). Notably, the termination codons for these
sORFs are also highly conserved in that although three
of the four overlapping PB1 codons in frame 1 are not
themselves highly conserved at the RNA level, a stop
codon is almost always (>99.9% for both sORF1 and 2)
maintained in frame 2 (Table 2). This degree of conserva-
tion is suggestive of functional importance, potentially for
the regulation of translation of the downstream PB1-F2
and N40 cistrons. Accordingly, we set out to further de-
lineate the mechanisms controlling translation from
segment 2 mRNA by systematically introducing muta-
tions into AUGs 1–4 and their ﬂanking regions that
would be predicted to alter their usage.
The sequences surrounding AUG1 are highly
conserved, and conform to a moderately strong initiation
consensus (Table 1). Upstream residues were modiﬁed to
each of the other possibilities at the crucial 3 position in
the T22A, T22G and T22C mutants (Figure 1B), with the
A/G changes but not the U!C alteration expected to
result in increased ribosome recognition of the AUG
(23,24) (Figure 1C). A further set of segment 2 AUG1
variants were produced on the background of the
previous mutants in which the upstream residues at pos-
itions 1 and 2 were changed to match the canonical
Kozak consensus (ACC, CCC, TCC mutants). The initi-
ation context of AUG1 was also weakened by mutating
the G at the+4 position to an A (G28A); this change also
resulted in a non synonymous D2N change in the pre-
dicted PB1 translation product (Figure 1B and C).
Similar approaches were taken to probe the function of
AUG2 and 3 in regulating translation. The context of
these initiation codons was improved by mutating the
+4nt to G (T32G and C74G respectively, which caused
V3G and A17G changes in the PB1 ORF, respectively).
Additionally, AUGs 2 and 3 were individually destroyed
(T30C and T72C respectively) without altering the PB1
amino acid sequence. Two further mutations were made
to examine the importance of AUG3/sORF2. A78T
removes the stop codon from sORF2, and thus the pre-
dicted frame 2 protein product from this construct is an
N-terminal fusion to PB1-F2. To investigate if the length
and position of sORF2 was important (as in the case of a
reinitiation event), a stop codon was re-introduced prior
to AUG4, in the A78T+G101T mutant. This mutant left
only 15 nt between the stop codon and AUG4, and also
produced a G26V alteration in the PB1 sequence. Finally,
AUG4 was removed by a T120C alteration, as used by
many previous studies to ablate PB1-F2 expression
(6,10,13,14,16,17,33,34). The positions of all mutations
are shown on the PR8 segment 2 sequence in Figure 1B
Table 2. Conservation of segment 2 50-sORF stop codons
Noa. Codonb 10 Codon 11 No
sORF 1 Stop codon:
3660 TTG (L) AAA (K) 6590
3309 CTA (L) AAG (K) 2073
1491 TTA (L) AGA (R) 10
218 CTG (L) AGG (R) 3
2 ATA (I) AAT (N) 1
2 GTA (V)
1 CTT (L) GTG (V) 1
1 TTT (F) GAA (E) 4
1 TCG (S) GAG (E) 4
1 CCG (P)
MPDc: 0.87 0.73
No. Codon 18 Codon 19 No.
sORF 2 Stop codon:
8677 ATA (I) AGC (S) 6688
3 GTA (V) AGT (S) 1995
1 CTA (L) AAC (N) 1
2 ATT (I) GGT (G) 1
2 ATC (I) TGC (C) 1
1 ACA (T)
MPD: 0 0.77
aNumber of viruses with the listed codon. Codons are grouped into
those that do and do not maintain the sORF stop codon (above and
below the line respectively).
bPB1 codon number and (encoded amino acid).
cNormalized mean pairwise distance of the PB1 codon. Low values
reﬂect high conservation in the data set (41).
Table 1. AUG codons in the 50-end of PR8 segment 2




1 AUU UGA AUG G Med 0.03 1/PB1 100
2 GAA UGG AUG U Weak 0.03/0.01 2/sORF-1 99.2
3 CAC AAA AUG C Med 0.03 2/sORF-2 99.3
4 ACA GCC AUG G High 0.01 2/PB1-F2 99.7
5 UAC ACC AUG G High 0.05 1/PB1 99.6
aAUG number from 50-end (Figure 1A).
bKozak consensus sequence (ideally GCCRCCAUGG) surrounding the
AUG.
cThe initiation context of the AUG is scored as ‘weak’, ‘medium’ or
‘high’, depending on the identity of the critical nucleotides at positions
3 and +4.
dPB1 codons showing evidence of RNA-level conservation (41) are
underlined and the normalized mean pairwise distance (MPD) score
given. Low values indicate high conservation. Values calculated from
an expanded database of 8686 unique full length segment 2 sequences
available on Genbank in January 2011.
eThe reading frame and ORF which the AUG initiates or is in
frame with.
fThe % of virus sequences that contain the particular AUG.
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and their predicted effects on AUG context and ORF
structure are summarized in diagrammatic form in
Figure 1C.
Segment 2 polypeptide synthesis in vitro
Initially, PB1 and N40 protein synthesis by the mutants
was investigated using coupled in vitro transcription and
translation (IVT) in rabbit reticulocyte lysate. As expected
(7) wild-type (WT) PR8 segment 2 expressed both PB1
and N40, with preferential usage of AUG1 (Figure 2A,
lane 1). All changes tested in the 3 to 1 positions
relative to AUG1 lead to notable increases in the expres-
sion of PB1 (lanes 2–7). Quantiﬁcation of replicate experi-
ments showed these increases to be at least 2-fold relative
to the WT gene (Figure 2D). Although this was the pre-
dicted outcome when the U at the 3 position was
swapped to a purine, a similar effect when it was
replaced with another pyrimidine was unexpected (23).
Consistent with a role for leaky scanning in accessing
downstream AUGs, a concomitant reduction in N40
levels was observed in all cases (Figure 2D). Conversely,
weakening the Kozak consensus of AUG1 through re-
placement of the+4G nucleotide downregulated PB1 ex-
pression, and although the absolute amount of N40
remained similar (Figure 2A, lane 8, quantiﬁcation in
Figure 2D), its ratio relative to PB1 was increased
1.7-fold compared to wild-type segment 2. In contrast,
mutations affecting AUGs 2 or 3, whether by altering
their context (T32G and C74G) or by destroying them
(T30C and T72C) had little effect on the ratio of PB1 to
N40 (Figure 2B; quantiﬁcation in Figure 2D). Similarly,
increasing the length of sORF2 (A78T+G101T) or fusing
it with the PB1-F2 cistron (A78T) did not substantially
alter relative use of AUGs 1 and 5. However, loss of the
PB1-F2 AUG4 through the T120C mutation increased
N40 synthesis from AUG5 by nearly 3-fold (Figure 2B,
lane 8, Figure 2D). This recapitulated our previous obser-
vation for a construct in which AUG4 was mutated and its
surrounding Kozak consensus disrupted [AUG; (7)].
The small size (10 kDa) of the PB1-F2 polypeptide
made it difﬁcult to visualize directly in IVT reactions.
Accordingly, we utilized a set of constructs in which the
CAT gene was fused downstream of AUG5 to increase the
size of the polypeptide products. Examination of IVT re-
actions programmed with plasmids containing the CAT
gene inserted into WT segment 2 in each of the three
reading frames showed the expected set of polypeptides:
frame one produced PB1 and PB1-N40 fusion proteins,
frame 2 produced a PB1-F2 fusion while frame 3 lacked
an obvious polypeptide product (Figure 2C, lanes 1–3
respectively). The quantity of the frame 2 product
synthesized showed partial correlation with the presence
and number of upstream AUG codons. For example, im-
proving the Kozak consensus of AUG1 had only a small
effect on PB1-F2-CAT synthesis (T22A: Figure 2C, lane 4;
quantiﬁcation in Figure 2D) and nor was F2 synthesis
Figure 2. Expression of segment 2 polypeptides in vitro. SDS–PAGE and autoradiographic analysis of aliquots of rabbit reticulocyte lysate supple-
mented with 35S-Methionine programmed with (A, B) full length clones of WT or mutant segment 2 clones as indicated or (C) segment 2 clones fused
to the CAT gene in frames 1, 2 or 3 as shown. The migration of polypeptides of interest is indicated. The lower panel in (C) shows a portion of the
gel stained with Coomassie Blue dye (CB) as a loading control. (D) Levels of PB1, PB1-N40 and PB1-F2 were quantiﬁed by densitometry and
normalized to those of the WT construct. The mean±SEM [n 3, with the exception of T22C (n=2), TCC and CCC (n=1)] are plotted. Asterisks
indicate levels of signiﬁcance based on P-values from a one sample t-test with the test value set to 1; *P< 0.05; **P< 0.01; ***P< 0.001.
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increased by the G28A mutation that weakened the
context of AUG1 (Figure 2C, lane 5). Similarly, alteration
of AUG2 by the T30C and T32G mutations had little
effect (lanes 6 and 7). In contrast, the level of PB1-F2
was up-regulated 2-fold when AUG3 was removed via
the T72C change (lane 8). The C74G mutation, predicted
to improve the Kozak consensus of AUG3 caused a slight
(<2-fold) reduction in F2 expression that was not statis-
tically signiﬁcant (lane 9). These results suggested that
while AUG2 was of little translational signiﬁcance,
AUG3 was recognized well by ribosomes and directly
regulated the level of PB1-F2 expression. Supporting
this, when sORF2 was fused to the F2 ORF through
removal of the intervening stop codon in the +2 frame
by the A78T mutation, increased levels of a slightly
longer (presumed) fusion protein were seen (lane 10).
Thus overall, the data suggested that expression of
PB1-F2 and PB1-N40 in vitro could be partially but not
wholly explained by leaky ribosomal scanning. AUGs 1,
3 and 4 were clearly functional and exerted a signiﬁcant
inﬂuence on use of downstream start codons. The poor
context AUG2 however, was apparently not used.
Generation of viruses with altered segment 2
translational regulatory sequences
Next, we wished to examine the behaviour of the mutant
segment 2 genes in the context of virus infection. However,
four of the mutants had non-synonymous changes in
PB1 (G28A; D2N, T32G; V3G, C74G; A17G and
A78T+G101T; G26V).
We therefore ﬁrst tested the ability of the mutant
PB1 polypeptides to support viral gene expression in
‘minireplicon’ assays (26,35). To reconstitute active viral
RNPs, plasmids encoding the three inﬂuenza A virus poly-
merase proteins and nucleoprotein were co-transfected
with a further plasmid that expressed a synthetic vRNA
molecule encoding luciferase in antisense from an RNA
polymerase I promoter. The luciferase levels in transfected
cells therefore represent a measure of the transcriptional
activity of the polymerase complex. When luciferase
values were normalized to those obtained with WT PB1,
all of the segment 2 mutants with unaltered PB1 sequences
gave values that ﬂuctuated around the 100% mark
(between 62 and 129% of normal), while a sample from
cells lacking PB1 gave <1% output (Figure 3A). However,
three of the four non-synonymous changes in PB1 were
deleterious to transcriptional activity. The T32G (V3G)
and A78T+G101T (G26V) polymerases were the most
impaired, with luciferase readings of 13 and 20% of WT
respectively. The G28A mutant (D2N) was marginally
impaired, producing luciferase activity at 54% of WT.
Only the C74G mutant (A17G, a relatively conservative
change) supported transcriptional activity in the range of
that observed with the mutants with synonymous changes
in PB1 (72%). The reduced ability of the T32G and
A78T+G101T mutants to support virus gene expression
was also seen when authentic segment 7 was used as a
RNP substrate and M1 and M2 accumulation analysed
by western blot (data not shown) or when unspliced
segment 7 mRNA accumulation was measured by
reverse transcriptase-primer extension assay (Figure 3B).
WT and the 13 mutant viruses were therefore generated
by transfection of cells with plasmids encoding the eight
segments in cDNA form (27,30). Notwithstanding the
reduced transcriptional activity associated with some of
the non-synonymous changes in PB1, it was possible to
rescue all of the mutants. Virus stocks were ampliﬁed in
MDCK cells and titred as a ﬁrst assessment of virus ﬁtness
(7,30,31). For the mutants with non-synonymous changes
in PB1, the endpoint titres showed a strong correlation
Figure 3. Transcriptional activity and growth properties of the mutant
segment 2 PB1 proteins and virus. (A, B) 293T cells were transfected
with plasmids encoding PB2, PA, NP, and WT or mutant PB1 proteins
(or as a negative control, lacking PB1; 2PNP), along with (A) a syn-
thetic vRNA analogue containing a luciferase gene and the luciferase
activity determined 48 h later or (B) a plasmid expressing authentic
segment 7 vRNA followed by reverse transcriptase-primer extension
analysis of segment 7 mRNA accumulation or (as a loading control),
5S rRNA. The data in (A) are the mean±SEM of 4–6 independent
experiments performed in duplicate, normalized to the values obtained
using WT PB1. Mutants with non-synonymous changes in PB1 are
indicated with diamonds. (C) The indicated viruses were rescued in
293T cells and ampliﬁed in MDCK cells before being titred by
plaque assay on MDCK cells. Data shown are the mean±SEM of
at least two independent rescues.
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with polymerase activity in the minireplicon system. The
most deﬁcient virus in this system (T32G) rescued only
once out of four attempts in 293T and MDCK cells,
where it showed a six log10 growth defect relative to
wild-type virus (Figure 3C). The A78T+G101T mutant
was successfully rescued ﬁve times out of seven tested
and reached endpoint titres of 1% of WT. All other
mutants rescued on every attempt (between two and six
times each). The G28A mutant, which had a 2-fold reduc-
tion in transcriptional activity, had a growth defect of
10-fold. Only the C74G virus grew similar levels as
WT virus. However, not all viruses with unaltered PB1
coding sequences grew normally. Three of the mutant
viruses with alterations around AUG1 (ACC, CCC and
TCC), showed growth defects of between 8- and 20-fold
relative to WT virus. In contrast, the T22A, T22G and
T22C viruses grew normally, despite also having muta-
tions to the upstream Kozak consensus of AUG1 that
showed similar perturbations to segment 2 translation in
the IVT system to the ACC, CCC and TCC changes.
Similar relative results were also obtained when virus
stocks were passaged in embryonated eggs, although
here the T32G virus grew better, to 106 PFU/ml or
0.5% of the WT control (data not shown).
Segment 2 polypeptide synthesis in infected cells
Low level expression of the replicative machinery is a
general feature of many viruses and in some cases, muta-
tions that result in overexpression of the viral polymerase
have been shown to be deleterious to virus ﬁtness (36,37).
It was therefore possible that the poor replication of the
ACC, CCC and TCC mutants resulted from
overexpression of PB1, although as noted above, the
T22A, T22C and T22G viruses did not show growth
defects. More generally, we wished to compare segment
2 protein expression from recombinant and authentic viral
settings. Accordingly, PB1, N40 and PB1-F2 accumula-
tion in MDCK cells infected with the panel of viruses
was examined at 8 h post-infection (p.i.) by western
blotting. To provide numerical data, the levels of each
protein from replicate experiments were quantiﬁed and
normalized to levels in cells infected with WT PR8. The
results obtained could be divided into those that were in
concordance the previous in vitro analysis, and those that
differed. In agreement, weakening the Kozak consensus of
AUG1 (G28A) reduced PB1 accumulation relative to N40
and F2 expression (Figure 4A, compare lanes 2 and 9;
quantiﬁcation in Figure 4B). Similarly, mutation of
AUG2 had little effect on either the quantity (T30C) or
the relative ratios (T32G) of the segment 2 polypeptides
(Figure 4A, lanes 12 and 13), with the lower levels of all
three polypeptides seen with the latter virus being plaus-
ibly ascribed to the reduced polymerase activity of the
mutant PB1 protein, as NP accumulation was also
reduced. Also in agreement, loss of AUG4 increased
N40 synthesis by 6-fold (T120C; lane 20), as we previ-
ously observed for a similar mutant virus (7).
The ﬁrst major discrepancy between the infection and
in vitro data concerned the role of AUG3 in controlling
expression of the downstream ORFs. The virus lacking
AUG3 (T72C) showed a statistically signiﬁcant 3-fold
increase in PB1-F2 accumulation relative to WT
(compare lanes 11 and 14), and this was consistent both
with the in vitro data and the proposed role for leaky
ribosomal scanning in accessing AUG4. Unlike in vitro
however, there was a concomitant (and statistically signiﬁ-
cant) 2-fold reduction in N40 levels, despite normal PB1
accumulation. This result was not possible to reconcile
with a model where leaky ribosomal scanning was the
sole contributor to N40 expression, because removal of
an upstream ORF should, at worst, leave N40 levels un-
changed. Instead, we hypothesized that in vivo, ribosomes
terminating at the end of sORF2 are able to reinitiate at
AUG5, bypassing AUG4 because of the time taken to
reacquire the necessary initiation factors (22). In the
absence of AUG3, more ribosomes initiate at AUG4
due to leaky ribosomal scanning, and so F2 levels
increase. However, no ribosomes are available to reinitiate
at AUG5, and so N40 levels decline. Supporting this hy-
pothesis, when sORF2 was fused to PB1-F2 (A78T), N40
levels were reduced >2-fold (Figure 4A, lane 16). This
virus would also be unable to express N40 by reinitiation
from sORF2, due to the removal of the stop codon.
However, reintroducing a stop codon using the G101T
mutation reinstated N40 levels to 90% of wild-type
(lane 17).
To investigate the reinitiation hypothesis further, the
AUG3/sORF2 mutations were made on a AUG4
(T120C) virus background (Figure 4C). These viruses
were rescued and grew to comparable titre to wild-type
PR8 (data not shown). Western blotting was performed
on cells infected with these viruses, as well as (for com-
parison) from cells infected with the ‘parental’ T72C,
C74G, A78T and T120C. As before, preventing potential
reinitiation from AUG3/sORF2, using either the T72C or
A78T mutations in the presence of an intact AUG4
reduced levels of N40 (Figure 4A, compare lanes 19,
21 and 25), while improving the predicted strength of
AUG3 had little effect (lane 23). Also as before, removal
of AUG4 (T120C) led to a large increase in N40 levels
(lane 20). A very similar outcome was obtained when
the Kozak consensus of AUG3 was improved by the
C74G mutation (C74G+T120C; lane 24). When AUG3
and 4 were removed concurrently (T72+T120C), synthesis
of N40 was increased even further, to 14-fold greater
levels than with the WT virus (Figure 4B lane 22, quanti-
ﬁcation in Figure 4B). However, when sORF2 was fused
to the F2 ORF in the absence of AUG4, only a small
enhancement (on average, 1.4-fold over WT) of N40 syn-
thesis resulted (lane 26). If N40 expression was purely de-
pendent on leaky scanning to bypass AUGs 3 and 4, this
combination of mutations should have behaved identically
to T120C alone. Instead, the absence of AUG4 only
makes a signiﬁcant difference to N40 expression when
either sORF2 terminates before AUG5 or AUG3 is also
absent, consistent with a reinitiation mechanism for syn-
thesis of N40.
There were also discrepancies between virus infection
and in vitro data for the AUG3/sORF2 mutant A78T
virus regarding PB1-F2 expression, as the mutation
decreased accumulation of the protein to 50% of
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normal instead of increasing it. Equally however, there
was no evidence of expression of a larger form of
PB1-F2 (Figure 4A, lane 16). Here, we surmise that the
larger product was unstable in infected cells, and that the
remaining F2 expression came from ribosomes initiating
normally at AUG4 via leaky scanning. Consistent with
this hypothesis, combining the A78T and T120C muta-
tions (the latter removing AUG4) led to the loss of all
detectable PB1-F2 accumulation (Figure 4A, lane 26).
If PB1-F2 is accessed by leaky scanning but N40 is
accessed by reinitiation after translation of sORF2 then
the insertion of further AUG codons in the region between
the end of sORF2 and the beginning of the PB1-F2 ORF
at AUG4 would be predicted to decrease F2 expression
(through ‘soaking up’ initiation competent scanning ribo-
somes) but to have little effect on N40 expression because
they would be effectively invisible to scanning small
subunits that had terminated after reading sORF2 but
not yet had time to acquire new initiation factors. To
test this hypothesis, we introduced mutations that
created new strong context AUG codons in each of the
three reading frames in this region (Figure 5A). To permit
the analysis of mutations that were lethal to virus growth
and to try and minimize the effects of differing protein
stability on polypeptide accumulation, we created sets of
chimaeric plasmids containing the 50-end of segment 2 en-
compassing the PB1-F2 coding sequence followed by a
GFP ORF such that either PB1 (frame 1) or PB1-F2
(frame 2) were fused in frame (Figure 5B).
To validate this system, we ﬁrst retested the effect of the
key mutations affecting sORF2 and AUG4. Cells trans-
fected with a plasmid encoding the WT segment 2 fused in
frame 1 to GFP produced the expected ratio of PB1 and
PB1-N40-derived fusion proteins, while the frame 2 fusion
Figure 4. Expression of segment 2 polypeptides in virus-infected cells. (A) Lysates harvested at 8 h post-infection from MDCK cells infected (or
mock infected) with the indicated viruses were analysed by SDS–PAGE and western blotting for the indicated proteins. Tubulin was used as a
loading control. (B) Levels of PB1, PB1-N40 and PB1-F2 were quantiﬁed using LiCOR software and normalized to levels from WT infected cells.
The mean±SEM from at least two independent experiments are shown. (C) Predicted ORF structure of viruses with alterations to AUG3/sORF2
and AUG4 are shown. Asterisks indicate levels of signiﬁcance based on P-values from a one sample t-test with the test value set to 1; *P< 0.05;
P< 0.01; ***P< 0.001.
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construct produced the predicted PB1-F2-GFP fusion
protein (Figure 5C, lane 2). As in the recombinant virus
setting, mutation of AUG4 with the T120C change
up-regulated N40 expression and abolished F2 expression
(lane 3), while mutation of AUG3 by T72C had the
opposite effect of increasing accumulation of the
F2-GFP fusion but signiﬁcantly decreasing N40 synthesis
(lane 4, quantiﬁcation in Figure 5D). Similarly, fusion of
sORF2 and the F2 ORF by the A78T mutation signiﬁ-
cantly reduced N40 production (Figure 5C, compare lanes
10 and 11). In contrast to virus infection, this mutation
also increased accumulation of the F2-fusion polypep-
tides, presumably because of the greater stability
conferred by the GFP moiety. Both the decrease in N40
expression and the increase in F2 synthesis were reversed
by reinstating the sORF2 stop codon by the further
mutation G101T (lane 12). Thus this system successfully
recapitulated the regulatory effects seen in the context of
authentic virus infection.
Next, we tested the effect of introducing novel AUG
codons between the termination codon of sORF2 and
AUG4. Insertion of new AUG ‘A’ into the PB1 ORF by
mutating glycine codon at position 26 to ATG resulted in
the production of a prominent novel frame 1 product
(‘PB1-N26’) as well as a signiﬁcant reduction in the syn-
thesis of the PB1-F2 fusion protein (Figure 5C, compare
lanes 2 and 5, quantiﬁcation data in 5D). N40 synthesis
was however unaffected. These effects were speciﬁc to the
creation of a new AUG codon, since mutation of codon
G26 to ATC left expression of PB1-F2 unaltered (lane 6).
Similarly, when new AUG codon ‘B’ was introduced into
frame 2 by mutation of PB1 codon T25 to TAT (with the
50-A!T change avoiding the simultaneous introduction
of a stop codon in frame 3; Figure 5A), N40 expression
was not signiﬁcantly altered while F2 accumulation was
substantially reduced, partially at the expense of a slightly
longer N-terminally extended form (lane 7). Again, the
effect was speciﬁc to the AUG codon rather than
mutation of codon 25 per se, because its mutation to
CGT (B ctr) left F2 expression unchanged. N40 expression
was also insensitive to the introduction of an AUG codon
into frame 3, whereas F2 accumulation was reduced
>2-fold (codon ‘C’; lane 13). Once again, the paired
control mutation had no affect on PB1-F2 synthesis,
although unexpectedly, this change increased N40 accu-
mulation (lane 14). Overall therefore, PB1-F2 levels were
sensitive to the presence of start codons in all three frames
following sORF2, whereas PB1-N40 levels were not sig-
niﬁcantly affected. These data show a fundamental differ-
ence in how AUG codons 4 and 5 are accessed: ribosomes
can be diverted away from AUG4 by the insertion of new
upstream AUG codons in the ‘UTR’ following sORF2,
but AUG5 is insensitive to this approach. The simplest
explanation consistent with the data is that AUG4 is
Figure 5. Effect of novel AUG codons on expression of segment 2 polypeptides after plasmid transfection. (A) Sequence of mutations introduced
between sORF2 and AUG4. (B) Diagrammatic summary of the predicted ORF structure of plasmids encoding fusions between the 50-end of segment
2 and GFP in either frame 1 or frame 2. (C) Lysates from 293T cells harvested 48 h after transfection with the indicated plasmids infected were
analysed by SDS–PAGE and western blotting for GFP. Tubulin was used as a loading control. (D) Levels of PB1-, PB1-N40- and PB1-F2-GFP
fusion proteins were quantiﬁed using LiCOR software and normalized to levels from WT infected cells. The mean±SEM from at least three
independent experiments are shown. Asterisks indicate levels of signiﬁcance based on P-values from a one sample t-test with the test value set to 1;
*P< 0.05; **P< 0.01; ***P< 0.001.
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primarily accessed by leaky ribosomal scanning that
bypasses AUGs 1–3, while AUG5 is reached by
reinitiation of ribosomes that have recently terminated
synthesis after translation of sORF2.
Packaging of mutant segment 2 vRNAs into virus
particles
The other major source of divergence between the in vitro
data and that observed from the virus infections was seen
with the mutants where the Kozak consensus of AUG1
was up-regulated. While the levels of N40 and PB1-F2
were predictably reduced, in all cases, the cells infected
with these mutants also underexpressed PB1 relative to
the WT virus (Figure 4A, lanes 2–8), showing on
average 20–80% reductions in PB1 accumulation (Figure
4B). This was most pronounced for the triple AUG1
mutants, ACC, CCC and TCC, which produced 18, 32
and 47% of the PB1 levels of WT virus respectively.
This was in marked contrast to the in vitro translation
data, where PB1 levels were increased 2-fold over WT
(Figure 2). However, it should be noted that when the
ratios of the three segment 2 polypeptides were con-
sidered, their relative amounts changed as predicted for
leaky ribosomal scanning: N40 to PB1 levels were
reduced between 2-fold (T22G) and 1.5-fold (ACC) in
the AUG1 up mutants while PB1-F2: PB1 ratios
decreased on average by 3-fold. Furthermore, transfec-
tion experiments conﬁrmed that the AUG1 up mutations
produced elevated amounts of PB1 in a cellular environ-
ment when introduced via plasmid (data not shown). We
therefore considered the alternative hypothesis that in the
background of authentic viruses, the AUG1 mutations
also perturbed segment speciﬁc packaging. It is well estab-
lished that the terminal unique coding and non-coding
regions of all segments (including the regions of segment
2 under investigation here) contain speciﬁc packaging
signals (3,38–42). In this hypothesis, the growth defect of
the AUG1 mutants and their failure to express normal, let
alone elevated quantities of PB1 could be explained by
reduced delivery of segment 2 to the infected cells
because of underincorporation of the segment into virions.
First, we measured virus particle formation by the panel
of mutant viruses by HA assay. This showed only small
ﬂuctuations in particle assembly and release, with even the
most replication deﬁcient virus, T32G, showing on
average, only a 4-fold drop in HA titre (Figure 6A).
Figure 6. Particle:PFU ratio and vRNA content of WT and mutant virus particles. (A) Virus release was measured by HA assay. Values are plotted
after normalization with respect to WT virus and are the mean±SEM of at least two independent isolations, with the exception of T22G, T22C,
CCC and A78T+G101T, which were only analysed once. (B) The ratio (normalized with respect to the WT virus) of HAU:PFU values are plotted, to
provide a measure of the proportion of infectious virus particles. (C and D) RNA was extracted from equal PFU of the indicated viruses and (C)
analysed by urea–PAGE and silver staining. The migration of individual segments is indicated. (D) Extracted RNA was analysed by one step qRT–
PCR for segments 2, 3, 5 and 7. The copy numbers obtained for the mutant viruses were normalized to that of the WT virus to derive a relative
segment copy number:PFU ratio. Data plotted are the mean±SEM from at least two independent extractions, and for each extraction, the qRT–
PCR reaction was performed in triplicate, with the exception of T32G and A78T+G101T, where RNA was extracted from a single rescue (the mean
of triplicate determinations is plotted).
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These data were then used to derive the proportion of
infectious virus particles by calculating the ratio of
HAU to PFU. By this measure, most mutants possessed
values similar to that of the WT virus; the ACC, G28A
and T32G viruses however had notably higher particle to
infectivity ratios, indicating a large number of defective
virions (Figure 6B).
To examine genome packaging in the segment 2 mutant
viruses directly, vRNA was extracted from equal plaque
titres of virus. The segments were resolved and detected by
Urea-PAGE and silver staining, and in all cases the
expected pattern of seven vRNA segments were seen
(Figure 6C; under these conditions, segments 1 and 2
comigrate). Obviously greater quantities of RNA were re-
covered from the ACC and TCC viruses (compare lanes 2,
6 and 8), a ﬁnding suggestive of an increased genome
copy: PFU ratio and thus consistent with a raised virus
particle: PFU ratio (30,31). However, the inability of this
gel system to reliably separate the three largest genome
segments hampered direct analysis of segment 2. In
addition, the poor growth of the T32G virus made it dif-
ﬁcult to extract sufﬁcient vRNA to detect by this proced-
ure (data not shown). We therefore used quantitative RT–
PCR (qRT–PCR) to examine the copy number of
segments in the mutant viruses. RNA was again extracted
from equal PFU of virus and one step RT–qPCR was
performed for segments 2, 3, 5 and 7. The amounts of
each segment from the mutant viruses were normalized
to that of the WT virus to derive a segment copy
number:PFU ratio. The T30C AUG2 mutant and all
AUG 3 and 4 mutants had similar levels of each of the
segments tested to the WT virus, and also had equivalent
amounts of each segment within each virus (Figure 6D).
In contrast, most of the AUG1 up-mutants underincor-
porated segment 2. In addition, the ACC, CCC, TCC
up-mutants as well as the AUG1 G28A and AUG2
T32G down-mutants showed several fold increases in the
relative amounts of the other three segments. Since vRNA
was extracted from equal numbers of infectious virus
particles, these results are consistent with a speciﬁc
packaging defect for segment 2 resulting in a higher
number of defective virions and thus a higher segment
copy number:PFU ratio of the other segments
(30,31,42). This is consistent with the hypothesis that the
failure of the AUG1 mutants with an improved Kozak
consensus to express elevated quantities of PB1 in
infected cells results from lower delivery of the segment
by infecting virions.
To further test this hypothesis, we analysed segment 2
RNA accumulation in cells infected with the ACC (as a
representative of an AUG1 up-mutant), G28A and T32G
viruses in comparison with WT and two mutant viruses
(T30C and T72C) with no obvious packaging defects.
All three RNA species (m-, c- and vRNA) were readily
detectable in samples from cells infected with the WT,
T30C and T72C viruses (Figure 7A, lanes 2, 5 and 7).
However, the three viruses with apparent defects in
segment 2 vRNA packaging produced much reduced
quantities of vRNA and (with the exception of G28A),
m- and cRNA also (lanes 3, 4 and 6). This defect was
particularly apparent for segment 2, as more consistent
levels of segment 7 vRNA were seen for all the viruses
(Figure 7A). When replicate experiments were quantiﬁed,
the three viruses with potential packaging defects
produced <10% of the normal amount of segment 2
vRNA (Figure 7B).
Although the above data were consistent with reduced
delivery of the vRNA by the infecting viruses, we also
considered the possibility that the AUG1/2 Kozak muta-
tions perturbed the function of the viral RNA promoter
(either the 30-end of vRNA or the 50-end of cRNA). This
could lead to a reduction in segment 2 vRNA levels with a
potential secondary effect of reducing the quantity avail-
able to be packaged into virions. Although the mutations
lie well outside of the conserved promoter region, there are
precedents for sequence alterations in the non-unique
regions of a segment affecting RNA synthesis (30,43,44).
To examine this possibility in isolation, the amount of
segment 2 produced from RNPs reconstituted by transfec-
tion was measured. Wild-type PB2, PB1, PA and NP were
transfected into cells with the reverse genetics plasmids
encoding the mutant segment 2 vRNAs. The segment 2
plasmids would be transcribed by RNA Polymerase I to
produce a negative sense segment 2 transcript that would
be encapsidated, transcribed and replicated by the WT
RNP proteins. In addition, mutant PB1 protein would
be also be expressed from the vRNAs with non synonym-
ous changes to the PB1 gene (G28A, T32G), but the
addition of wild-type PB1 would be expected to at least
partially compensate for this. Thus this system allowed us
to examine viral RNA production from the mutant
segments in isolation from potentially confounding
issues of segment delivery and PB1 protein function.
Forty-eight hours post-transfection, RNA was harvested
and primer extension analysis for segment 2 v, m and
cRNA was performed. Omitting PB2 from the transfec-
tions determined the baseline levels of segment 2 vRNA
that were expressed from the pPolI promoter (Figure 7C,
lane 1). In the presence of the full 3PNP complex, the
mutant segment 2 constructs were transcribed and
replicated to broadly similar extents (Figure 7C). When
replicate experiments were quantiﬁed, the AUG1
mutants and the T32G AUG2 mutant accumulated
vRNA to >75% of the WT level, in clear contrast to the
>10-fold reductions they exhibited in the context of virus
infection (Figure 7B). Similarly, all mutants expressed m-
and cRNA to reasonable levels, with, on average, no
change of >2-fold compared to the WT (Figure 7D).
These data argue against a defect in the promoter
sequence of the viral RNA being solely responsible for
the reduced levels of viral RNA seen in the context of
infection and support instead the hypothesis that muta-
tions around AUG1 not only affect translation initiation
of PB1 and downstream cistrons, but also affect genome
packaging.
DISCUSSION
The single known species of segment 2 mRNA produces
three proteins: PB1, PB1-F2 and PB1-N40. PB1 is an
essential protein, encoding the potential antiviral drug
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target of an RNA polymerase, while PB1-F2 modulates
pathogenicity in some host–virus combinations and the
function of N40 is unknown. Despite representing the
only known functionally tri-cistronic inﬂuenza virus
mRNA, the mechanisms that control protein expression
from the segment have not been fully elucidated. Here, we
conﬁrm the hypothesis that leaky ribosomal scanning has
a role in mediating expression of PB1-F2 and PB1-N40.
However, this mechanism does not fully explain segment 2
translation and we also identify ribosomal reinitiation
after sORF2 as important for PB1-N40 expression.
Our data further reﬁne the model for segment 2 protein
expression. PB1 translation occurs via the canonical
pathway of eukaryotic translation initiation (22) in
which a preinitiation complex consisting of an eIF2a-
ternary complex (eIF2-TC) attached to a 40S ribosomal
subunit scans 30-wards from the 50-cap structure, recog-
nizes AUG1 and commences translation after loss of the
initiation factors and recruitment of the 60S subunit
(Figure 8A). The simplest explanation for PB1-F2 expres-
sion is that it occurs via leaky ribosomal scanning, in
which the preinitiation complex misses the moderate
context AUGs 1 and 3 and the poor context AUG2
before initiating translation at the strong context AUG4
(Figure 8B). AUG3/sORF2 evidently plays an important
role in down-regulating use of AUG4, as its loss through
the T72 mutation substantially increased PB1-F2 accumu-
lation, in vitro and in the context of virus infection.
In contrast, the presence of AUG3/sORF2 up-regulated
N40 expression in infected cells, a ﬁnding inconsistent
with leaky scanning. Instead, we think this is best ex-
plained via leaky ribosomal scanning to bypass AUGs 1
and 2 followed by initiation at AUG3, almost immediate
termination at the end of the two codon sORF2 and
continued scanning of the 40S ribosomal subunit. The
40S subunit then scans past the strong context AUG4
but has time to reacquire an eIF2-TC before reaching
the strong context AUG5 whereupon translation initiation
occurs (Figure 8C). The distances between the sORF2
stop codon and AUGs 4 and 5 (40 and 63 nt respectively)
are consistent with previously characterized instances of
reinitiation (22,45–47). In some circumstances, changes in
levels of eIF2-TC during conditions of cell stress (as for
example when virus infection activates PKR) are known
to regulate expression of downstream ORFs accessed via
reinitiation strategies (22). It is therefore interesting to
speculate that segment 2 translation might be further
regulated during the course of infection.
Figure 7. Accumulation of viral RNA in infected and transfected cells. Total cellular RNA extracted from 293T cells was analysed by
reverse-transcriptase primer extension with radiolabelled oligonucleotides speciﬁc for the indicated RNAs followed by urea–PAGE and autoradiog-
raphy. (A) RNA was harvested at 9 h post-infection from cells infected (or mock infected) with the indicated viruses. (B) RNA was extracted from
cells 48 h after transfection with plasmids to recreate viral RNPs around the indicated segment 2 vRNAs. Lane 1 shows the background levels of
vRNA produced from the segment 2 plasmid by cellular RNA PolI in the absence of a full viral polymerase complex. (C and D) Accumulation of the
indicated RNAs was quantiﬁed by densitometry and normalized to the value obtained with the WT after correction with respect to the 5S ribosomal
RNA loading control. The mean±range of two independent experiments are plotted.
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The distance between the extended sORF2 in the A78T
mutant and the N40 AUG (39 nt) is similar to that
between the normal sORF2 and the PB1-F2 AUG, so
we would not rule out the possibility that reinitiation
after sORF2 translation also contributes to F2 expression.
However, shortening the intercistronic distance between
sORF2 and the F2 ORF to 18 nt (a distance predicted
to be too short to allow efﬁcient reacquisition of an
eIF2-TC) in the A78T+G101T mutant did not signiﬁcant-
ly reduce F2 accumulation, so we do not think it plays a
major role.
Another major conclusion from this study is that the
50-end of segment 2 mRNA itself has a number of
overlapping functions. These include coding sequences
critical for PB1 function, regulation of expression of
downstream ORFs and also regions important for
vRNA packaging. This has practical implications by
reinforcing that this region represents an attractive
target for therapeutic intervention, either by anti-viral
drugs [e.g. those targeting the PB1–PA protein interface;
(48)] or through T-cell epitope immunization (49), because
the chance of ﬁnding escape mutations that maintain all
functions of the protein/RNA sequence is likely to be
lower than in a less functionally intricate area of the
virus genome. Understanding the overlapping functional
requirements also provides an interesting perspective on
the evolutionary selection pressures that could be
operating in this region of the inﬂuenza genome.
Packaging signals have been previously mapped to the
general area of the 30-end of segment 2 vRNA (38–41)
(summarized in Figure 9) but this is the ﬁrst study to
show that the same nucleotides also contribute to transla-
tional regulatory sequences. This ﬁnding echoes our
previous ﬁnding that sequences important for directing
packaging of segment 7 overlap other cis-acting signals
for mRNA splicing (30) and further demonstrates the
functional complexities contained within sections of the
inﬂuenza A virus genome. Examining the sequence of
the 50-end of segment 2 (in mRNA sense) using the criter-
ion of reporting sequences that are conserved in >95% of
the available isolates makes it evident that the primary
selection pressure acting on the region is PB1 function
(50). By this admittedly simple measure, only two amino
acid residues (positions 12 and 14) are not conserved, in
obvious contrast to PB1-F2 or sORF1 and sORF2. At the
nucleotide level, as previously noted (50), it is clear that
the majority of sequence polymorphisms are found at the
third base position of the PB1 gene (Figure 9). Consistent
with this, experimental evidence shows that the majority
of the 14N-terminal amino acids as well as (where tested)
Figure 8. Model for translation of segment 2 polypeptides. PB1 translation occurs by canonical initiation at the ﬁrst AUG. The majority of PB1-F2
translation occurs via leaky scanning to bypass AUGs 1–3. In contrast, reinitiation after termination at the end of sORF2 is a major contributor
to PB1-N40 translation. See text for further details.
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residues further downstream, are important for one or
more functions of PA binding, polymerase activity and
virus replication (21,51–53) (and data presented in this
study). However, although over half of the ﬁrst 41
codons of PB1 show some variability at the wobble
position, it is notable that the primary translational
signals within this region are much more highly conserved,
with all ﬁve start codons showing >99% conservation and
only one of the two stop codons (that of sORF1) showing
apparent variation (Figure 9, Tables 1 and 2). Even here,
as discussed, the variation is such that >99.9% of viruses
maintain either a UGA or UAA stop codon (Table 2).
That AUG1 is essential for PB1 expression is obvious;
the moderate Kozak consensus surrounding it has pre-
sumably evolved to allow expression of one or more of
the downstream ORFs via leaky scanning. This sequence
element appears be additionally selected for via the con-
tribution these nucleotides make to the segment 2 speciﬁc
packaging signal. However, in light of the theory that
RNA viruses gain additional genes through selection of
unused or poorly expressed ORFs (54) and that a selective
advantage for PB1-F2 or N40 is not always obvious
(7–9,17,18,55), it is not clear which functional element
came ﬁrst. AUG2 or sORF1 seems to be of no signiﬁcance
as a translational element since modulation of the AUG
made no difference to protein expression in vitro or in
virus infected cells. Similarly, removal of the stop codon
had no effect on segment 2 protein expression, genome
packaging or virus replication (data not shown). The
AUG may be retained because PB1 function requires an
aspartate residue at position 2 [this study; (21,51,52,56)]
and because the wobble position of codon 2 has become
ﬁxed through its secondary role in the segment packaging
signal. Retention of the stop codon is more difﬁcult to
explain, although positions 10 and 11 require leucine
and lysine respectively (21,51,52,56) and of the twelve
possible permutations of this codon pair, only two do
not result in a termination codon.
AUG5 may be maintained either because methionine
40 is essential for PB1 function and/or because expression
of N40 supplies a selective advantage in vivo, for reasons
as yet unknown. However, an isoleucine change at
position 40 does not obviously inhibit PB1 transcriptase
activity or inhibit virus growth in vitro or in eggs (6,7),
perhaps favouring the latter hypothesis. AUG4 is presum-
ably conserved at least in part to allow expression of
PB1-F2, although it is less obvious what maintains it in
the large number of viruses (9,57) that do not possess an
intact F2 ORF. It does not seem to contribute to a
packaging signal, so one possibility is that it is retained
as a ‘ribosome sink’ to prevent overexpression of N40.
AUG3 and the stop codon for sORF2 also seem likely
to be conserved for a regulatory role: depressing PB1-F2
synthesis and/or permitting N40 expression. Since neither
PB1-F2 or PB1-N40 is required for virus replication in cell
culture, elucidating which (if either) of these roles is more
important for maintaining virus ﬁtness (as well as the
wider question of their function in virus pathogenicity)
will require either animal experiments and/or more
sophisticated model systems for virus replication in vitro.
Understanding the mechanisms that underlie F2 and N40
expression informs the design of virus mutants that could
answer these questions.
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